ScholarIQanswers from OpenAlex & ORCID
Michael L. Reed
ResearcherPublications, citations & collaboration network
Michael L. Reed is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael L. Reed have?
ScholarIQindexed works
Michael L. Reed has 417 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael L. Reed have?
ScholarIQcitation count
Michael L. Reed has 24,325 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael L. Reed?
ScholarIQh-index
Michael L. Reed has an h-index of 75 in OpenAlex.
What is the i10-index of Michael L. Reed?
ScholarIQi10-index
Michael L. Reed has an i10-index of 194 in OpenAlex.
What is the ORCID of Michael L. Reed?
ScholarIQorcid
The ORCID for Michael L. Reed is on the source record.
What is the OpenAlex record for Michael L. Reed?
ScholarIQopenalex
The OpenAlex for Michael L. Reed is on the source record.
What are the most-cited papers on Michael L. Reed?
ScholarIQmost cited works
Migraine prevalence, disease burden, and the need for preventive therapy
Richard B. Lipton, Marcelo E. Bigal, Merle L. Diamond, Frederick G. Freitag, Michael L. Reed, Walter F. Stewart
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Richard B. Lipton, Walter F. Stewart, Seymour Diamond, Merle L. Diamond, Michael L. Reed
Migraine Diagnosis and Treatment: Results From the American Migraine Study II
Richard B. Lipton, Seymour Diamond, Michael L. Reed, Merle L. Diamond, Walter F. Stewart
Screening for Bipolar Disorder in the Community
Robert M. A. Hirschfeld, Joseph R. Calabrese, Myrna M. Weissman, Michael L. Reed, Marilyn A. Davies, Mark A. Frye, Paul E. Keck, Lydia Lewis, Susan L. McElroy, James McNulty, Karen Dineen Wagner
Cutaneous allodynia in the migraine population
Richard B. Lipton, Marcelo E. Bigal, Sait Ashina, Rami Burstein, Stephen D. Silberstein, Michael L. Reed, Daniel Serrano, Walter F. Stewart, American Migraine Prevalence Prevention Advisory Group